HR
TTOO

Howe & Rusling’s T2 Biosystems, Inc TTOO Stock Holding History

Howe & Rusling’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed -$1K – 1222
2022
Q2 		$1K Sell
1
-2
-67% -$2.96K ﹤0.01% 1026
2022
Q1 		$8K Hold
3
– – ﹤0.01% 567
2021
Q4 		$8K Hold
3
– – ﹤0.01% 582
2021
Q3 		$14K Hold
3
– – ﹤0.01% 467
2021
Q2 		$18K Hold
3
– – ﹤0.01% 415
2021
Q1 		$24K Hold
3
– – ﹤0.01% 376
2020
Q4 		$19K Hold
3
– – ﹤0.01% 401
2020
Q3 		$20K Buy
+3
New +$22.2K ﹤0.01% 352

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Howe & Rusling's TTOO Position: Q3 2022 in Review

Howe & Rusling sold out of T2 Biosystems, Inc (TTOO) in Q3 2022, closing a stake of 1 share — an estimated $1K sold.

Howe & Rusling first reported a position in TTOO in Q3 2020 and held it in 8 quarters. The position peaked at $24K in Q1 2021. 54 funds tracked by Wall St. Rank hold TTOO as of Q3 2022.

  • Howe & Rusling reported no remaining T2 Biosystems, Inc position as of Q3 2022 after selling out during the quarter.
  • Howe & Rusling sold 1 T2 Biosystems, Inc share in Q3 2022, an estimated $1K.
  • Howe & Rusling first reported a position in T2 Biosystems, Inc in Q3 2020 and held it in 8 quarters.
  • Howe & Rusling's T2 Biosystems, Inc position peaked at $24K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2022.

Based on Howe & Rusling's 13F filing for Q3 2022, filed 14 Nov 2022.